Could a poop pill tame inflammation? new trial tests FMT for arthritis and bowel disease

NCT ID NCT04924270

Recruiting now Disease control Sponsor: Odense University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether fecal microbiota transplants (FMT) given as capsules can safely improve symptoms in people newly diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, or ulcerative colitis. Two hundred participants will receive either FMT or a placebo weekly for a month, along with standard anti-inflammatory treatment. The goal is to see if adding FMT helps control disease better than standard care alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis Crohn disease psoriatic arthritis pulmonary sarcoidosis rheumatoid arthritis ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANKYLOSING SPONDYLITIS CROHN DISEASE PSORIATIC ARTHRITIS RHEUMATOID ARTHRITIS ULCERATIVE COLITIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Odense University Hospital
RECRUITING

Odense, Denmark

Contact